Brief: Bpl-003 Demonstrates Rapid And Durable Antidepressant Effects In Treatment-Resistant Depression Phase 2A Data Published In Journal Of Psychopharmacology Phase 3 Program On Track For Q2 2026 Initiation
March 17 (Reuters) - AtaiBeckley Inc ATAI.O: BPL-003 DEMONSTRATES RAPID AND DURABLE ANTIDEPRESSANT EFFECTS IN TREATMENT-RESISTANT DEPRESSION; PHASE 2A DATA PUBLISHED IN JOURNAL OF PSYCHOPHARMACOLOGY; PHASE 3 PROGRAM ON TRACK FOR Q2 2026 INITIATION Source text: ID:nGNX3PfWrM Further company coverage: ATAI.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on AtaiBeckley
See all newsFDA to hold public hearing on psychedelic drugs as Trump-driven push gathers pace
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM